• About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact
Investors Investors

Investors

Abcuro.com

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact

Investors

aberdeen

January 31, 2025

Bain Capital Life Sciences

August 17, 2023

BlackRock

August 18, 2023

Eurofarma

August 17, 2023

Foresite Capital

February 11, 2025

Hongsen Investment

September 17, 2021

Mass General Brigham Ventures

September 17, 2021

NEA

February 11, 2025

New Leaf Venture Partners

August 17, 2023

Pontifax

September 17, 2021

RA Capital

September 17, 2021

Redmile Group, LLC

August 17, 2023

Rock Springs Capital

August 13, 2026

Samsara Biocapital

September 17, 2021

Sanofi Ventures

September 17, 2021

Soleus Capital

August 17, 2023

Privacy Terms of Use

© 2026 Abcuro